Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice

Bioconjugate Chemistry

Volumn 17, Issue 3, 2006, Pages 662-669

  Cheng, Zhen ^a   Levi, Jelena ^a   Xiong, Zhengming ^a,b   Gheysens, Olivier ^a   Keren, Shay ^a   Chen, Xiaoyuan ^a   Gambhir, Sanjiv Sam ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; CONTROLLED DRUG DELIVERY; DIAGNOSIS; DISEASE CONTROL; DISEASES; FLUORESCENCE IMAGING; GLUCOSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED DEVICES; MAMMALS; TARGETED DRUG DELIVERY;

D-GLUCOSAMINE; D-GLUCOSE; GLUCOSE TRANSPORTERS; MONOFUNCTIONAL; N-HYDROXYSUCCINIMIDE; NEAR INFRARED; NEAR-INFRARED; NEAR-INFRARED FLUORESCENT; TUMOR CELL LINES; TUMOUR CELLS;

TUMORS;

2 [N (7 NITROBENZ 2 OXA 1,3 DIAZOL 4 YL)AMINO] 2 DEOXY DEXTRO GLUCOSE; DEOXYGLUCOSE; FLUORESCENT DYE; FLUORODEOXYGLUCOSE F 18; GLUCOSAMINE; GLUCOSE; GLUCOSE TRANSPORTER; HEXOKINASE; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CANCER GRAFT; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG TUMOR LEVEL; FEASIBILITY STUDY; FEMALE; FLUORESCENCE MICROSCOPE; FLUORESCENCE MICROSCOPY; GLIOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMAGING SYSTEM; MELANOMA; METABOLIC RATE; MOLECULAR SIZE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PURIFICATION; QUANTITATIVE ANALYSIS; TUMOR LOCALIZATION; TUMOR MODEL;

ANIMALIA;

EID: 33646937992     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050345c     Document Type: Article

References (35)

1. Gambhir, S. S. (2002) Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2, 683-693.
2. 18F-FDG in oncology. J. Nucl. Med. Technol. 30, 3-9.
3. Wahl, R. (1996) Positron emission tomography: Applications in oncology. In Nuclear Medicine (Henkin, R. V., Boles, M. A., Dillehay, G. L., et al., Eds.) pp 1524-1545, Mosby, St. Louis, MO.
4. 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma. J. Nucl Med. 43, 940-947.
5. Warburg, O. (1931) The Metabolism of Tumors, pp 129-169, Richard R. Smith, Inc., New York.
6. Wahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., and Cody, R. (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation. J. Clin. Oncol. 11, 2101-2111.
7. Lapela, M., Eigtved, A., Jyrkkio, S., Grenman, R., Kurki, T., Lindholm, P., Nuutinen, J., Sutinen, E., Solin, O., Bjornskov, I., Bretlau, P., Friberg, L., Holm, S., Jensen, M., Sand Hansen, H., and Minn, H. (2000) Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur. J. Cancer 36, 858-867.
8. Akhurst, T., Downey, R. J., Ginsberg, M. S., Gonen, M., Bains, M., Korst, R., Ginsberg, R. J., Rusch, V. W., and Larson, S. M. (2002) An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann. Thorac. Surg. 73, 259-264.
9. 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J. Nucl. Med. 45, 17-21.
10. Joensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S., Capdeville, R., Dimitrijevic, S., Druker, B., and Demetri, G. D. (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med. 344, 1052-1056.
11. Schibli, R., Dumas, C., Petrig, J., Spadola, L., Scapozza, L., Garcia-Garayoa, E., and Schubiger, P. A. (2005) Synthesis and in vitro characterization of organometallic rhenium and technetium glucose complexes against Glut 1 and hexokinase. Bioconjugate Chem. 16, 105-112.
12. 99mTc ECDG targeted at the multifunctional glucose transport system: Feasibility study with rodents. Radiology 226, 465-473.
13. Massoud, T. F., and Gambhir, S. S. (2003) Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev. 17, 545-580.
14. Ntziachristos, V., Bremer, C., and Weissleder, R. (2003) Fluorescence imaging with near-infrared light: New technological advances that enable in vivo molecular imaging. Eur. Radiol. 13, 195-208.
15. Mahmood, U., and Weissleder, R. (2003) Near-infrared optical imaging of proteases in cancer. Mol. Cancer Ther. 2, 489-496.
16. Achilefu, S. (2004) Lighting up tumors with receptor-specific optical molecular probes. Technol. Cancer Res. Treat. 3, 393-409.
17. Sevick-Muraca, E. M., Houston, J. P., and Gurfinkel, M. (2002) Fluorescence-enhanced, near-infrared diagnostic imaging with contrast agents. Curr. Opin. Chem. Biol. 6, 642-650.
18. Hawrysz, D. J., and Sevick-Muraca, E. M. (2000) Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia 2, 388-417.
19. Yamada, K., Nakata, M., Horimoto, N., Saito, M., Matsuoka, H., and Inagaki, N. (2000) Measurement of glucose uptake and intracellular calcium concentration in single, living pancreatic β-cells. J. Biol. Chem. 275, 22278-22283.
20. Yoshioka, K., Takahashi, H., Homma, T., Saito, M., Oh, K. B., Nemoto, Y., and Matsuoka, H. (1996) A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. Biochim. Biophys. Acta 1289, 5-9.
21. Yoshioka, K., Saito, M., Oh, K. B., Nemoto, Y., Matsuoka, H., Natsume, M., and Abe, H. (1996) Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells. Biosci. Biotechnol. Biochem. 60, 1899-1901.
22. Lloyd, P. G., Hardin, C. D., and Sturek, M. (1999) Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog. Physiol. Res. 48, 401-410.
23. Oh, K. B., and Matsuoka, H. (2002) Rapid viability assessment of yeast cells using vital staining with 2-NBDG, a fluorescent derivative of glucose. Int. J. Food Microbiol. 76, 47-53.
24. Zhang, M., Zhang, Z., Blessington, D., Li, H., Busch, T. M., Madrak, V., Miles, J., Chance, B., Glickson, J. D., and Zheng, G. (2003) Pyropheophorbide 2-deoxyglucosamide: A new photosensitizer targeting glucose transporters. Bioconjugate Chem. 14, 709-714.
25. Ye, Y., Bloch, S., and Achilefu, S. (2004) Polyvalent carbocyanine molecular beacons for molecular recognitions. J. Am. Chem. Soc. 126, 7740-7741.
26. Ye, Y., Bloch, S., Kao, J., and Achilefu, S. (2005) Multivalent carbocyanine molecular probes: Synthesis and applications. Bioconjugate Chem. 16, 51-61.
27. O'Neil, R. G., Wu, L., and Mullani, N. (2005) Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol. Imaging Biol. 7, 1-5.
28. Ke, S., Wen, X., Gurfinkel, M., Charasangavej, C., Wallace, S., Sevick-Muraca, E. M., and Li, C. (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res. 63, 7870-7875.
29. Ballou, B., Fisher, G. W., Deng, J. S., Hakala, T. R., Srivastava, M., and Farkas, D. L. (1998) Cyanine fluorochrome-labeled antibodies in vivo: Assessment of tumor imaging using Cy3, CyS, Cy5.5, and Cy7. Cancer Detect. Prev. 22, 251-257.
30. 3 in brain tumor xenografts. Cancer Res. 64, 8009-8014.
31. Ntziachristos, V., Schellenberger, E. A., Ripoll, J., Yessayan, D., Graves, E., Bogdanov, A., Jr., Josephson, L., and Weissleder, R. (2004) Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc. Natl. Acad. Sci. U.S.A. 101, 12294-12299.
32. Law, B., Curino, A., Bugge, T. H., Weissleder, R., and Tung, C. H. (2004) Design, synthesis, and characterization of urokinase plasminogen-activator- sensitive near-infrared reporter. Chem. Biol. 11, 99-106.
33. Mansch, A., Frey, O., Hilger, I., Sauner, D., Haas, M., Schmidt, D., Kurrat, C., Gajda, M., Malich, A., Brauer, R., and Kaiser, W. A. (2004) Diagnosis of arthritis using near-infrared fluorochrome Cy5.5. Invest. Radiol. 39, 626-632.
34. Ballou, B., Fisher, G. W., Waggoner, A. S., Farkas, D. L., Reiland, J. M., Jaffe, R., Mujumdar, R. B., Mujumdar, S. R., and Hakala, T. R. (1995) Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies. Cancer Immunol. Immunother. 41, 257-263.
35. 3 expression in living mice. Bioconjugate Chem. 16, 1433-1441.